Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families.

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Abstract Text:

Antonio del Sol,Hirotomo Fujihashi,Dolors Amoros,Ruth Nussinov,

The representation of protein structures as small-world networks facilitates the search for topological determinants, which may relate to functionally important residues. Here, we aimed to investigate the performance of residue centrality, viewed as a family fold characteristic, in identifying functionally important residues in protein families. Our study is based on 46 families, including 29 enzyme and 17 non-enzyme families. A total of 80% of these central positions corresponded to active site residues or residues in direct contact with these sites. For enzyme families, this percentage increased to 91%, while for non-enzyme families the percentage decreased substantially to 48%. A total of 70% of these central positions are located in catalytic sites in the enzyme families, 64% are in hetero-atom binding sites in those families binding hetero-atoms, and only 16% belong to protein-protein interfaces in families with protein-protein interaction data. These differences reflect the active site shape: enzyme active sites locate in surface clefts, hetero-atom binding residues are in deep cavities, while protein-protein interactions involve a more planar configuration. On the other hand, not all surface cavities or clefts are comprised of central residues. Thus, closeness centrality identifies functionally important residues in enzymes. While here we focus on binding sites, we expect to identify key residues for the integration and transmission of the information to the rest of the protein, reflecting the relationship between fold and function. Residue centrality is more conserved than the protein sequence, emphasizing the robustness of protein structures.

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Publishing Authors By Initials

A del Sol,H Fujihashi,D Amoros,R Nussinov,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Intr

Journal: Protein science : a publication of the Protein Soc

VOLUME: 15

Page Numbers: 2120-8

Journal Abbreviation:

ISSN: 0961-8368

DAY: 1

MONTH: 08

YEAR: 2006

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9211750

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families.

AFFILIATION: Bioinformatics Research Unit, Research and Development Division, Tokyo, Japan. ao-mesa@fujirebio.co.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Protein Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families Related Publications

• "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.
• A hierarchical protein folding scheme based on the building block folding model.
• Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.
• Allostery: Absence of a Change in Shape Does Not Imply that Allostery Is Not at Play.
• Backbone conformational preferences and pseudorotational ring puckering of 1-aminocyclopentane-1-carboxylic acid.
• Changing the charge distribution of beta-helical-based nanostructures can provide the conditions for charge transfer.
• Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect.
• Consensus features in amyloid fibrils: sheet-sheet recognition via a (polar or nonpolar) zipper structure.
• Designing a nanotube using naturally occurring protein building blocks.
• How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding.
• Interaction of protegrin-1 with lipid bilayers: membrane thinning effect.
• Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities.
• Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.
• Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages.
• MolAxis: a server for identification of channels in macromolecules.
• Molecular dynamics simulations of Alzheimer Abeta40 elongation and lateral association.
• Nanostructure design using protein building blocks enhanced by conformationally constrained synthetic residues.
• New structures help the modeling of toxic amyloidss ion channels.
• Principles of nanostructure design with protein building blocks.
• Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families.
• Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets.
• Similar binding sites and different partners: implications to shared proteins in cellular pathways.
• Simulations as analytical tools to understand protein aggregation and predict amyloid conformation.
• Structural basis for p53 binding-induced DNA bending.
• Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4.
• Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35.
• Structure by design: from single proteins and their building blocks to nanostructures.
• Towards drugs targeting multiple proteins in a systems biology approach.
• Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design.
• p53-Induced DNA bending: the interplay between p53-DNA and p53-p53 interactions.